FDA Inspection 1164119 — Long Island Jewish Medical Center

Long Island Jewish Medical Center — FEI 2472215

The FDA completed an inspection of Long Island Jewish Medical Center on Mar 10, 2022 in New Hyde Park, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 10, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
New Hyde Park, NY (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs